nitrates has been researched along with thalidomide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Koch, H | 1 |
Abe, F; Hasegawa, T; Kanazawa, H; Kondo, T; Miyamoto, K; Nadai, M; Saito, H; Takagi, K; Ueyama, J; Wakusawa, S; Zhao, YL | 1 |
Amirshahrokhi, K; Ghazi-Khansari, M | 1 |
Korshunov, VA; Maluccio, MA; Skill, NJ; Theodorakis, NG; Wang, YN | 1 |
4 other study(ies) available for nitrates and thalidomide
Article | Year |
---|---|
[Germination and growth inhibitory effect of thalidomide and different analeptics on embryos of Lepidium sativum].
Topics: Aminobutyrates; Caffeine; Camphor; Carbonates; Central Nervous System Stimulants; Depression, Chemical; Ephedrine; Ethanolamines; Nikethamide; Nitrates; Pentylenetetrazole; Phenobarbital; Seeds; Sodium; Strychnine; Sympathomimetics; Thalidomide | 1969 |
Effect of thalidomide on endotoxin-induced decreases in activity and expression of hepatic cytochrome P450 3A2.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Down-Regulation; Drug Synergism; Endotoxins; Enzyme-Linked Immunosorbent Assay; Immunosuppressive Agents; Liver; Male; Membrane Proteins; Nitrates; Nitrites; Pharmaceutical Preparations; Rats; Rats, Wistar; Spectrophotometry, Ultraviolet; Thalidomide; Tumor Necrosis Factor-alpha | 2008 |
Thalidomide attenuates multiple low-dose streptozotocin-induced diabetes in mice by inhibition of proinflammatory cytokines.
Topics: Administration, Oral; Animals; Cytokines; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hyperglycemia; Inflammation Mediators; Insulin; Male; Mice; Nitrates; Nitrites; Thalidomide | 2012 |
Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
Topics: Animals; Antihypertensive Agents; Aorta, Abdominal; Arterial Pressure; Biomarkers; Blood Flow Velocity; Disease Models, Animal; Hypertension, Portal; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Portal Pressure; RAW 264.7 Cells; Regional Blood Flow; Signal Transduction; Thalidomide; Time Factors; Tumor Necrosis Factor-alpha | 2015 |